Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Conditions:   Recurrent Nasopharyngeal Carcinoma;   Metastatic Nasopharyngeal Carcinoma
Intervention:   Drug: Anlotinib plus gemcitabine/cisplatin
Sponsor:   Chinese Academy of Medical Sciences
Not yet recruiting

https://ift.tt/2NacKle